Cui, H., Feng, C., Zhang, T., Martnez-Ros, V., Martorell, P., Tortajada, M., Cheng, S., Cheng, S., & Duan, Z
In cases of early dementia or AD, GLP-1RA treatment protected metabolism and network connections in the brain, but did not significantly alter biomarkers associated with -amyloid or tau protein
A high-quality protein shake (20-30g protein) can be easier to consume than a full meal, especially when nauseous
Over time, these processes gradually become less efficient, leading to the accumulation of biological changes that affect metabolism, tissue function, and resilience across organ systems
Keeping supplements visible and easy to access may also help reduce skipped days
In this context, therapies such as GLP-1RAs may represent a complementary strategy aimed at modulating both metabolic dysfunction and inflammation, thereby optimizing disease control and improving long-term outcomes in PsA